Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

News & Analysis

China biotech company and industry news and analysis...

Tianjin's CanSino to Raise $160.5 Million for Novel Vaccines in Hong Kong IPO

BGI's GenoImmune Raises $18 Million for Neoantigen Discovery Services

Merck Signs MOU with GenScript for China Plasmid and Viral Vector Manufacturing

I-Mab Starts US Trial of GM-CSF Immunotherapy for Rheumatoid Arthritis

Sinopharm Partners with ImmBio on Broad-Spectrum Pneumonia Vaccine

Upcoming event
Shanghai , China
May 8-9, 2019
Take advanage of the early bird discount before March 31, 2019.
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event

Shanghai , China
March 26-28, 2019